サンプル依頼リスト カート
  • Korean
表紙：女性の健康診断市場 - 2030年までの世界の見通しと予測
市場調査レポート
商品コード
1771762

女性の健康診断市場 - 2030年までの世界の見通しと予測

Women's Health Diagnostic Markets: Global Outlook and Forecast to 2030

出版日
ページ情報
英文 210 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
女性の健康診断市場 - 2030年までの世界の見通しと予測
出版日: 2025年07月14日
発行: Kalorama Information
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

「女性の健康診断市場 - 2030年までの世界の見通しと予測」では、臨床、ポイントオブケア（POC）、一般用医薬品（OTC）の各分野における女性の健康に特化した診断検査の世界の状況について、包括的かつデータに基づいて分析しています。世界の人口動態が変化し、女性が男性よりも長生きするようになるにつれ、ヘルスケアシステムは、疾病リスク、スクリーニング、治療における性差を認識し、それに対処する必要に迫られています。診断薬はこの変革の中核であり、女性の生涯にわたって個別化されたタイムリーな介入を提供する能力を備えています。

この詳細なレポートでは、2030年までの診断検査と診断システムの世界市場動向を予測し、女性の健康に関連する幅広い診断カテゴリーについて地域区分と動向分析を行います。本調査では、女性特有の、あるいは女性の間で非常に流行している疾患の検出、スクリーニング、モニタリングに使用される既存技術と新興技術の両方を網羅しています。市場規模は、機器設置やソフトウェアサポートなどの関連サービスを含む製品とシステムの売上高を反映しています。

当レポートでカバーしている主な診断分野は以下の通りです。

  • 乳房と生殖器の健康イメージング：マンモグラフィ、CADe/CADx、産婦人科超音波、乳房超音波画像診断
  • 出生前検査とキャリアスクリーニング：非侵襲的出生前検査（NIPT）、キャリアスクリーニング、母体胎児診断
  • 感染症および性感染症：HPV診断、TORCHイムノアッセイ、分子尿路感染症（UTI）検査
  • 不妊および妊娠検査：排卵、排卵ホルモン、妊娠状態のラボベースおよびPOC検査
  • がんおよび慢性疾患のモニタリング：パップテスト、卵巣がんバイオマーカー、女性特異的自己免疫免疫測定
  • 骨の健康と予防診断：早期がん発見のための骨密度測定検査とコルポスコピーシステム

各章では、規制の変化、償還、市場参入、製品の差別化などの課題を取り上げながら、各カテゴリーの成長を牽引する科学的基盤や技術革新を探求しています。本レポートでは、業界専門家へのインタビュー、臨床ラボからの情報、広範な1次調査と2次調査をもとに、市場予測とトレンド評価を行っています。

圧倒的な多国籍企業から軽快なニッチ企業まで、多様な診断薬参入企業を各カテゴリーで紹介しています。BD、GE Healthcare、Hologic、Roche、Siemens Healthineers、Thermo Fisherなどが含まれています。これらの企業は、バイオマーカー、自動化、デジタル画像化、在宅検査などのイノベーションを通じて、女性診断の未来を積極的に形成しています。

診断検査が医療上の意思決定の70％以上を左右する現在、当レポートは女性健康診断学を成長市場としてだけでなく、精密医療の重要な構成要素として位置づけています。当レポートに含まれる洞察は、アクセスの拡大、臨床転帰の改善、そして女性の進化する健康ニーズに合わせた次世代の診断ソリューションへの投資に注力する利害関係者にとって不可欠なものです。

目次

調査会社について

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • 女性の健康：改善の余地
  • 女性の健康に関する視点
  • 女性と男性ではいくつかの病気の発症が異なる
    • 疼痛
    • 心臓
    • 脳
    • 感情
    • 骨の構造
    • アルコール
    • 薬の副作用
    • 喫煙
    • 生殖能力
    • 性感染症とHIV
    • 自己免疫疾患
    • がん
    • 女性に多いがん
    • 筋骨格系の健康
    • 先天異常
    • 尿路感染症（UTI）
  • 女性の健康診断における主要な動向と課題
    • 卵巣がんの診断とバイオマーカー
    • HPV検査
    • より広範なキャリアスクリーニングとNIPT
    • 尿路感染症のマルチプレックス検査と分子検査
    • イメージングとAI
    • 妊娠と排卵
    • 自己免疫検査

第3章 マンモグラフィ

  • イントロダクション
  • マンモグラフィ市場
  • コンピュータ支援検出/診断（CADe/CADx）
  • 乳房画像診断における人工知能の導入
  • 規制の変更
  • 競合情勢
    • Fujifilm Holdings Corp.
    • GE HealthCare
    • Hologic
    • Siemens Healthineers

第4章 超音波

  • イントロダクション
  • 産婦人科
  • 乳房画像検査
  • 市場動向
  • 産婦人科超音波の動向
  • 乳房画像診断市場
  • 競合情勢
    • GE HealthCare
    • Hologic
    • Philips
    • Siemens Healthineers

第5章 出生前スクリーニングとキャリアスクリーニング

  • イントロダクション
  • NIPT
  • 遺伝学の進歩は新たな課題をもたらす
  • キャリアスクリーニング
  • テスト導入動向
  • 遺伝性疾患
  • M&A、パートナーシップ
  • NIPTとキャリアスクリーニング市場
  • 競合情勢
    • Agilent
    • Illumina
    • Qiagen
    • Revvity
    • Thermo Fisher Scientific

第6章 HPV検査

  • イントロダクション
  • 概要
  • HPV IVD検査市場
  • HPV検査と世界スクリーニングプログラム
  • 競合情勢
    • BD (Becton, Dickinson and Company) Hologic QIAGEN Roche

第7章 妊娠と排卵

  • イントロダクション
  • テストに関する視点
  • デジタルテスト
  • ラボテスト
  • 動向
  • 市場
  • 製品
  • TORCHテスト
  • 競合情勢
    • 市場参入企業
    • NowDiagnostics Inc.
    • Salignostics
    • Sekisui
    • Acon
    • Major Companies
    • Abbott
    • Beckman Coulter (Danaher)
    • bioMerieux
    • Church & Dwight
    • Roche
    • Siemens Healthineers

第8章 パップスメア検査

  • イントロダクション
  • 子宮頸がん検査
  • 動向
  • パップテスト市場
  • 競合情勢
    • BD (Becton Dickinson)
    • Hologic

第9章 自己免疫疾患

  • イントロダクション
  • 遺伝的要因
  • 女性患者への影響
  • 最近の動向
  • 女性自己免疫疾患のラボベースの免疫測定市場
  • 競合情勢
    • Bio-Rad
    • Euroimmun (Revvity)
    • Thermo Fisher Scientific

第10章 骨密度検査

  • イントロダクション
  • 骨粗鬆症の驚くべき増加
  • 測定の必要性を推進
  • DEXAと競合技術の動向
  • 骨密度測定市場
  • 競合情勢
    • DMS Imaging (European Medical Solutions)
    • GE HealthCare
    • Hologic

第11章 膣鏡検査

  • イントロダクション
  • 子宮頸がんのスクリーニングと診断
  • 動向
  • 膣鏡検査システム市場
  • 競合情勢
    • Apgar Danmark A/S
    • CooperSurgical
    • Olympus

第12章 尿路感染症

  • イントロダクション
  • 罹患と死亡の主な原因
  • インパクト
  • 動向
  • 技術の進歩が臨床ガイドラインを上回る
  • 次世代シーケンシング（NGS）
  • マルチプレックスPCR、qPCR
  • UTI分子検査市場
  • 競合情勢
    • 中小企業の可能性
    • 企業のハイライト
    • BioGX
    • Camtech
    • PathogenDx
    • Randox Laboratories
    • RayBiotech
    • Thermo Fisher Scientific

第13章 卵巣がん

  • イントロダクション
  • 卵巣がんの種類
  • CA-125
  • 動向
  • 多変量インデックスアッセイとゲノム検査
  • 卵巣がんバイオマーカー市場
  • 競合情勢
    • 企業のハイライト
    • Abbott
    • Fujirebio
    • Illumina
    • Roche
    • Thermo Fisher Scientific
目次
Product Code: 25-072KA

Kalorama Information's "Women's Health Diagnostic Markets: Global Outlook and Forecast to 2030" offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women's health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift-with women living longer than men-healthcare systems are under increasing pressure to recognize and address sex-based differences in disease risk, screening, and treatment. Diagnostics are at the core of this transformation, offering the ability to deliver personalized and timely interventions across a woman's life span.

This in-depth report forecasts global market revenues for diagnostic tests and systems through 2030, providing regional segmentation and trend analysis across a broad spectrum of diagnostic categories relevant to female health. The study encompasses both established and emerging technologies used in the detection, screening, and monitoring of conditions unique to, or highly prevalent among, women. Market sizing reflects product and system sales, including associated services such as instrument installation and software support.

Key diagnostic sectors covered in the report include:

  • Breast and Reproductive Health Imaging: Mammography, CADe/CADx, OB/GYN ultrasound, and breast ultrasound imaging.
  • Prenatal and Carrier Screening: Non-invasive prenatal testing (NIPT), carrier screening, and maternal-fetal diagnostics.
  • Infectious and Sexually Transmitted Diseases: HPV diagnostics, TORCH immunoassays, and molecular urinary tract infection (UTI) testing.
  • Fertility and Pregnancy Testing: Lab-based and POC tests for ovulation, fertility hormones, and pregnancy status.
  • Cancer and Chronic Disease Monitoring: Pap tests, ovarian cancer biomarkers, and female-specific autoimmune immunoassays.
  • Bone Health and Preventive Diagnostics: Bone densitometry testing and colposcopy systems for early cancer detection.

Each chapter explores the scientific foundations and technological innovations driving growth in its respective category while addressing challenges such as regulatory shifts, reimbursement, market access, and product differentiation. The report draws on interviews with industry experts, input from clinical labs, and extensive primary and secondary research to inform market forecasts and trend assessments.

A diverse group of diagnostic players-ranging from dominant multinationals to nimble niche firms-are profiled in each category. Companies covered include BD, GE Healthcare, Hologic, Roche, Siemens Healthineers, and Thermo Fisher, among others. These firms are actively shaping the future of women's diagnostics through innovation in biomarkers, automation, digital imaging, and home-based testing.

At a time when diagnostic testing influences more than 70% of medical decisions, this report positions women's health diagnostics not only as a growing market but also as a critical component of precision medicine. The insights contained herein are essential for stakeholders focused on expanding access, improving clinical outcomes, and investing in the next generation of diagnostic solutions tailored to women's evolving health needs.

Table of Contents

About Kalorama Information

Chapter 1: Executive Summary

  • Overview
  • Scope and Methodology
  • Market Overview and Potential
    • Figure 1-1: World Markets for Key Women's Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]
    • Table 1-1: World Markets for Key Women's Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]

Chapter 2: Introduction

  • Female Health: Room for Improvement
  • Perspective on Women's Health
  • Women and Men Develop Some Diseases Differently
    • Pain
    • The Heart
    • The Brain
    • Emotions
    • Bone Structure
    • Alcohol
    • Drug Side Effects
    • Smoking
    • Fertility
    • STIs and HIV
    • Autoimmune Disease
    • Cancer
    • Leading Female Cancers
    • Musculoskeletal Health
    • Congenital Abnormalities
    • Urinary Tract Infections (UTIs)
  • Key Trends and Issues in Women's Health Diagnostics
    • Ovarian Cancer Diagnostics and Biomarkers
    • HPV Testing
    • Broader Carrier Screening and NIPT
    • Multiplex and Molecular Testing for UTIs
    • Imaging and AI
    • Pregnancy and Ovulation
    • Autoimmune Laboratory Immunoassays

Chapter 3: Mammography

  • Introduction
    • Transition to Digital
    • Economics of Routine Screening
    • Digital Breast Tomosynthesis (DBT or 3D Mammography)
  • Mammography Market
    • Table 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-2: World Mammography Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 3-3: World Mammography Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Computer-Aided Detection/Diagnosis (CADe/CADx)
    • Table 3-2: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-4: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-5: World CADe/CADx Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 3-6: World CADe/CADx Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Artificial Intelligence Adoption in Breast Imaging
    • Key Trends in AI-Driven CAD
    • Trends
  • Regulatory Changes
  • Competitive Landscape
    • Fujifilm Holdings Corp.
    • GE HealthCare
    • Hologic
    • Siemens Healthineers

Chapter 4: Ultrasound

  • Introduction
    • Table 4-1: Key Applications for Medical Ultrasound
  • Obstetrics and Gynecology
  • Breast Imaging
  • Market Trends
  • Obstetric and Gynecological Ultrasound Trends
    • Table 4-2: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-1: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-2: World Ultrasound OB/GYN Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 4-3: World Ultrasound OB/GYN Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Breast Imaging Market
    • Table 4-3: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-4: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-5: World Ultrasound Breast Imaging Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 4-6: World Ultrasound Breast Imaging Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • GE HealthCare
    • Hologic
    • Philips
    • Siemens Healthineers

Chapter 5: Prenatal and Carrier Screening

  • Introduction
  • NIPT
  • Advances in Genetics Bring New Challenges
  • Carrier Screening
  • Test Adoption Trends
  • Inherited Diseases
    • Inflammatory Bowel Disease (IBD) and Crohn's Disease
    • Autism Spectrum Disorder (ASD)
    • Alzheimer's Disease (AD)
    • Cardiovascular Disease (CVD)
    • Psychiatric Disorders
  • M&A, Partnerships
  • NIPT and Carrier Screening Markets
    • Table 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 5-2: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 5-3: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Agilent
    • Illumina
    • Qiagen
    • Revvity
    • Thermo Fisher Scientific

Chapter 6: HPV Testing

  • Introduction
  • Overview
    • HPV Infection
    • Infection in Females
    • High-Risk Types and Cervical Cancer
    • HPV Testing
  • HPV IVD Test Market
    • Table 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 6-2: World Female HPV IVD Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 6-3: World Female HPV IVD Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • HPV Testing and Global Screening Programs
  • Competitive Landscape
    • BD (Becton, Dickinson and Company)
    • Hologic
    • QIAGEN
    • Roche

Chapter 7: Pregnancy and Ovulation

  • Introduction
  • Perspective on Testing
  • Digital Testing
  • Lab Testing
  • Trends
  • Market
    • POC Pregnancy and Fertility Test Market
      • Table 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-2: World POC Pregnancy Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
      • Figure 7-3: World POC Pregnancy Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
      • Table 7-2: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-4: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-5: World Lab-Based Fertility Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
      • Figure 7-6: World Lab-Based Fertility Immunoassay Market, Share by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Products
  • TORCH Testing
    • Table 7-3: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 7-7: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 7-8: World Lab-Based TORCH Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 7-9: World Lab-Based TORCH Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Market Participants
    • NowDiagnostics Inc.
    • Salignostics
    • Sekisui
    • Acon
    • Major Companies
    • Abbott
    • Beckman Coulter (Danaher)
    • bioMerieux
    • Church & Dwight
    • Roche
    • Siemens Healthineers

Chapter 8: Pap Smears

  • Introduction
  • Testing for Cervical Cancer
  • Trends
  • Pap Test Market
    • Table 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 8-2: World IVD Traditional Pap Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 8-3: World IVD Traditional Pap Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • BD (Becton Dickinson)
    • Hologic

Chapter 9: Autoimmune Disease

  • Introduction
  • Genetic Factors
  • Impact on Female Patients
  • Recent Developments
  • Female Autoimmune Lab-Based Immunoassay Market
    • Table 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 9-2: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World] ($ million)
    • Figure 9-3: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Bio-Rad
    • Euroimmun (Revvity)
    • Thermo Fisher Scientific

Chapter 10: Bone Density Testing

  • Introduction
  • Alarming Rise in Osteoporosis
  • Propelling the Need for Measurement
  • Trends in DEXA and Competing Technologies
    • DEXA: The Gold Standard
    • Emerging Trends and Accessibility
  • Bone Densitometry Market
    • Table 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 10-2: World Bone Densitometry for Female Testing Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 10-3: World Bone Densitometry for Female Testing Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • DMS Imaging (European Medical Solutions)
    • GE HealthCare
    • Hologic

Chapter 11: Colposcopy

  • Introduction
  • Cervical Cancer Screening and Diagnosis
  • Trends
  • Colposcopy Systems Market
    • Table 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 11-2: World Colposcopy Systems Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 11-3: World Colposcopy Systems Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Apgar Danmark A/S
    • CooperSurgical
    • Olympus

Chapter 12: Urinary Tract Infections

  • Introduction
  • Leading Cause of Morbidity and Death
  • Impact
  • Trends
  • Technological Advances Outpace Clinical Guidelines
  • Next-Generation Sequencing (NGS)
  • Multiplex PCR, qPCR
  • UTI Molecular Test Market
    • Table 12-1: World Molecular UTI Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 12-1: World Molecular UTI Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 12-2: World Molecular UTI Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 12-3: World Molecular UTI Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Potential in Small Companies
    • Company Highlights
    • BioGX
    • Camtech
    • PathogenDx
    • Randox Laboratories
    • RayBiotech
    • Thermo Fisher Scientific

Chapter 13: Ovarian Cancer

  • Introduction
  • Types of Ovarian Cancer
  • CA-125
  • Trends
  • Multivariate Index Assays and Genomic Tests
  • Ovarian Cancer Biomarker Market
    • Table 13-1: World Ovarian Cancer Biomarkers Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 13-1: World Ovarian Cancer Biomarkers Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 13-2: World Ovarian Cancer Biomarkers Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 13-3: World Ovarian Cancer Biomarkers Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Company Highlights
    • Abbott
    • Fujirebio
    • Illumina
    • Roche
    • Thermo Fisher Scientific